CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market buy Chief Marketing Officer bought 12,800 shares at $20.83 ($266,591)
- 4 Open-market sale 10% owner sold 1,750,000 shares at $21.04 ($36,820,000)
- 4 Open-market buy Director bought 10,000 shares at $19.83 ($198,270)
- 4 Open-market sale 10% owner sold 1,000,000 shares at $18.80 ($18,800,000)
- 4 Grant or award Chief Marketing Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 8,600 shares at $28.88 ($248,353)
- 4 Open-market buy Director bought 2,200 shares at an average $28.54 ($62,780)
- 4 Open-market buy Director bought 2,898 shares at $34.94 ($101,256)
- 4 Open-market buy Director bought 7,142 shares at $29.19 ($208,471)
- 4 Open-market buy Director bought 7,000 shares at an average $25.16 ($176,148)
- 4 Grant or award SILVERNAIL LAUREN P acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 13 · 252 filings